MARCH 2024LIFE SCIENCES REVIEW6Gil Carrasquinho,VP Global Head of Strategy, Operations and Assets Cell and Gene BU,SantenHow Allogeneic Stem Cell Therapies Can Transform Prospects in Inherited Retinal Diseases22Marcia Matos,Clinical Operations HUB Director for APAC,SERVIERClinical Trials Landscape In APAC And Its Unique Characteristics And Opportunities17Kazuto Yamada,Senior Director, Head of Clinical Development Planning and Supervising Five R&D Functions, Otsuka PharmaceuticalEvolving Digital Biomarkers in Clinical Trial Space26Dr Israfil Merican,MD, MHM,Assistant Vice President - Head of Medical Affairs and Bioequivalent,Pharmaniaga BerhadHalal Biopharma: Closing the Therapeutic Gaps28CXO INSIGHTSCXO INSIGHTS
< Page 5 | Page 7 >